Table 1 Selected Baseline Characteristics by Treatment Status at Enrollment, REACH-OUT (2010–2013)
Variable | PP-All NÂ =Â 482 | PP-C NÂ =Â 308 | PP-N NÂ =Â 174 | OAT NÂ =Â 281 | P Value, PP-All vs OAT | P Value, PP-N vs OAT |
|---|---|---|---|---|---|---|
Age (Mean ± SD) | 41.12 ± 12.6 | 42.0 ± 12.7 | 39.6 ± 12.2 | 42.1 ± 13.4 | 0.440 | 0.069 |
Male | 344 (71%) | 219 (72%) | 125 (74%) | 181 (66%) | 0.046 | 0.074 |
Race | Â | Â | Â | Â | 0.727 | 0.081 |
 White | 239 (50%) | 170 (57%) | 69 (42%) | 133 (49%) |  |  |
 Black/African American | 153 (32%) | 80 (27%) | 73 (44%) | 90 (33%) |  |  |
 Multiracial/other | 73 (15%) | 49 (16%) | 24 (14%) | 48 (18%) |  |  |
Ethnicity: Hispanic | 65 (13%) | 43 (14%) | 22 (14%) | 72 (26%) | <0.001 | 0.002 |
Married/committed | 40 (8%) | 29 (10%) | 11 (7%) | 35 (13%) | 0.077 | 0.053 |
Medicare | 238 (49%) | 164 (55%) | 74 (45%) | 100 (38%) | <0.001 | 0.130 |
Medicaid | 352 (73%) | 236 (79%) | 116 (70%) | 169 (63%) | <0.001 | 0.119 |
Private residence | 326 (68%) | 213 (70%) | 113 (67%) | 212 (78%) | 0.002 | 0.015 |
Lung condition | 48 (10%) | 28 (9%) | 20 (12%) | 15 (5%) | 0.029 | 0.018 |
Smoking | 346 (72%) | 226 (74%) | 120 (70%) | 179 (64%) | 0.015 | 0.183 |
Alcohol abuse | 106 (22%) | 73 (24%) | 33 (19%) | 47 (17%) | 0.075 | 0.526 |
Substance abuse | 114 (24%) | 80 (26%) | 34 (20%) | 75 (27%) | 0.386 | 0.113 |
Duration of schizophrenia in years (mean ± SD) | 15.7 ± 12.9 | 16.5 ± 13.0 | 14.4 ± 12.5 | 13.9 ± 13.5 | 0.014 | 0.340 |
Paranoid schizophrenia | 323 (67%) | 203 (66%) | 120 (69%) | 178 (63%) | 0.306 | 0.226 |
Schizophrenia severity | Â | Â | Â | Â | <0.001 | <0.001 |
 Chronic | 169 (35%) | 108 (36%) | 61 (36%) | 72 (26%) |  |  |
 Subchronic | 118 (24%) | 68 (23%) | 50 (30%) | 61 (22%) |  |  |
 Other/unspecified | 180 (38%) | 123 (41%) | 57 (34%) | 148 (53%) |  |  |